Insight

drsandeepnayak.com

Jan 30, 2025, 06:00

Advancing insights in metastatic renal cell carcinoma – International Urology Cancer Summit

International Urology Cancer Summit shared a post on LinkedIn about a recent paper by

” ‘Role of Hb to RDW ratio in metastatic RCC patients treated with first-line immunotherapy combinations’ explores a promising prognostic factor to improve patient counselling and guide treatment decisions.

Well done to all the authors.

Advancing insights in metastatic renal cell carcinoma!”

“Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations”

Authors: Matilde Corianò, Alessandro Lazzarini, Michele Maffezzoli, Alessio Signori, Sebastiano Buti et al.

Advancing insights in metastatic renal cell carcinoma - International Urology Cancer Summit

More posts featuring International Urology Cancer Summit.

Alessandro Lazzarini Alessio Signori cancer International Urology Cancer Summit Matilde Corianò metastatic RCC Michele Maffezzoli OncoDaily Oncology renal cell carcinoma Sebastiano Buti

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer

FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial

New World Cancer Declaration 2025–2035 by UICC

Agenus Bets Big on Botensilimab

Carlos Rodriguez-Galindo: Childhood cancer has long been overlooked in global strategies - It is time to change that